Lumretuzumab

(Synonyms: Anti-Human ERBB3 Recombinant Antibody)
Kundenbewertung

Based on 1 Customer Validation

Lumretuzumab (Anti-Human ERBB3 Recombinant Antibody) is a humanized anti-HER3 (ERBB3) monoclonal antibody. Lumretuzumab effectively inhibits the activity of key oncogenic signaling pathways such as PI3K/AKT and MAPK. Lumretuzumab has been optimized through glycosyl engineering to enhance antibody-dependent cell-mediated cytotoxicity (ADCC). Lumretuzumab can be used to study HER3-positive, HER2-low-expressing solid tumors, especially breast cancer.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit : ≥99.0%
  • CAS. Nr.: 1448327-63-6
  • Molecular Weight:146.92 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Protokoll
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle EGFR Isoform-spezifische Produkte anzeigen

More

Alle PI3K Isoform-spezifische Produkte anzeigen

More

Alle Akt Isoform-spezifische Produkte anzeigen

More

Alle p38 MAPK Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00